NCT02129751: An ongoing trial by Bausch Health Americas, Inc.
This trial is ongoing. It must report results 4 years, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT02129751 |
|---|---|
| Title | A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 30, 2026 |
| Completion date | July 31, 2029 |
| Required reporting date | July 31, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |